Assessment of the Effectiveness of HPV16/18 Infection Referred for Colposcopy in Cervical Cancer Screening in Northwest of China.

about

Assessment of the Effectiveness of HPV16/18 Infection Referred for Colposcopy in Cervical Cancer Screening in Northwest of China.

Item

http://www.wikidata.org/entity/Q40133840

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Assessment of the Effectivenes ...... reening in Northwest of China.

@en

type

Item

label

Assessment of the Effectivenes ...... reening in Northwest of China.

@en

prefLabel

Assessment of the Effectivenes ...... reening in Northwest of China.

@en

P1476

Assessment of the effectivenes ...... creening in Northwest of China

@en

P2093

Di Cao

http://www.w3.org/2001/XMLSchema#string

Hongran Jia

http://www.w3.org/2001/XMLSchema#string

Juan Zhao

http://www.w3.org/2001/XMLSchema#string

Li Wang

http://www.w3.org/2001/XMLSchema#string

Meili Pei

http://www.w3.org/2001/XMLSchema#string

Minyi Zhao

http://www.w3.org/2001/XMLSchema#string

Shimin Quan

http://www.w3.org/2001/XMLSchema#string

Siyu Cao

http://www.w3.org/2001/XMLSchema#string

Ting Yang

http://www.w3.org/2001/XMLSchema#string

Xiaofeng Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Evaluation of HPV-16 and HPV-18 Genotyping for the Triage of Women With High-Risk HPV+ Cytology-Negative Results

Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test.

Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: data from the ATHENA trial.

Evaluation of a newly developed GenoArray human papillomavirus (HPV) genotyping assay and comparison with the Roche Linear Array HPV genotyping assay

A study of genotyping for management of human papillomavirus-positive, cytology-negative cervical screening results

Age-specific occurrence of HPV16- and HPV18-related cervical cancer.

Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States.

Eurogin 2010 roadmap on cervical cancer prevention.

Clinicians' attitude towards changes in Australian National Cervical Screening Program.

The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.

P304

165-171

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JMV.24902

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Qian Zhang

P577

2017-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28710863

http://www.w3.org/2001/XMLSchema#string

P932

5725729

http://www.w3.org/2001/XMLSchema#string